These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24327435)

  • 21. Design, synthesis, and biological evaluation of an antagonist-bombesin analogue as targeting vector.
    Abd-Elgaliel WR; Gallazzi F; Garrison JC; Rold TL; Sieckman GL; Figueroa SD; Hoffman TJ; Lever SZ
    Bioconjug Chem; 2008 Oct; 19(10):2040-8. PubMed ID: 18808168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bombesin analogues for gastrin-releasing peptide receptor imaging.
    Nanda PK; Pandey U; Bottenus BN; Rold TL; Sieckman GL; Szczodroski AF; Hoffman TJ; Smith CJ
    Nucl Med Biol; 2012 May; 39(4):461-71. PubMed ID: 22261143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumors.
    Abiraj K; Mansi R; Tamma ML; Fani M; Forrer F; Nicolas G; Cescato R; Reubi JC; Maecke HR
    J Nucl Med; 2011 Dec; 52(12):1970-8. PubMed ID: 22080443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1,2,3-Triazoles as amide-bond surrogates in peptidomimetics.
    Valverde IE; Mindt TL
    Chimia (Aarau); 2013; 67(4):262-6. PubMed ID: 23967702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical evaluation of a new bombesin analog for imaging of gastrin-releasing peptide receptors.
    Shirmardi SP; Gandomkar M; Maragheh MG; Shamsaei M
    Cancer Biother Radiopharm; 2011 Jun; 26(3):309-16. PubMed ID: 21711115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiochemical investigations of [188Re(H2O)(CO)3-diaminopropionic acid-SSS-bombesin(7-14)NH2]: syntheses, radiolabeling and in vitro/in vivo GRP receptor targeting studies.
    Smith CJ; Sieckman GL; Owen NK; Hayes DL; Mazuru DG; Volkert WA; Hoffman TJ
    Anticancer Res; 2003; 23(1A):63-70. PubMed ID: 12680195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical evaluation of a novel ¹¹¹In-labeled bombesin homodimer for improved imaging of GRPR-positive prostate cancer.
    Carlucci G; Ananias HJ; Yu Z; Hoving HD; Helfrich W; Dierckx RA; Liu S; de Jong IJ; Elsinga PH
    Mol Pharm; 2013 May; 10(5):1716-24. PubMed ID: 23590837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 18F-labeled BBN-RGD heterodimer for prostate cancer imaging.
    Li ZB; Wu Z; Chen K; Ryu EK; Chen X
    J Nucl Med; 2008 Mar; 49(3):453-61. PubMed ID: 18287274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu-NO2A-(X)-BBN(7-14)NH2], in a prostate tumor xenografted mouse model.
    Lane SR; Nanda P; Rold TL; Sieckman GL; Figueroa SD; Hoffman TJ; Jurisson SS; Smith CJ
    Nucl Med Biol; 2010 Oct; 37(7):751-61. PubMed ID: 20870150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The synthesis of 64Cu-chelated porphyrin photosensitizers and their tumor-targeting peptide conjugates for the evaluation of target cell uptake and PET image-based pharmacokinetics of targeted photodynamic therapy agents.
    Mukai H; Wada Y; Watanabe Y
    Ann Nucl Med; 2013 Aug; 27(7):625-39. PubMed ID: 23605059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and evaluation of bombesin analogues conjugated to two different triazolyl-derived chelators for (99m)Tc labeling.
    Brans L; García-Garayoa E; Schweinsberg C; Maes V; Struthers H; Schibli R; Tourwé D
    ChemMedChem; 2010 Oct; 5(10):1717-25. PubMed ID: 20806312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 18F-labeled bombesin analog for specific and effective targeting of prostate tumors expressing gastrin-releasing peptide receptors.
    Honer M; Mu L; Stellfeld T; Graham K; Martic M; Fischer CR; Lehmann L; Schubiger PA; Ametamey SM; Dinkelborg L; Srinivasan A; Borkowski S
    J Nucl Med; 2011 Feb; 52(2):270-8. PubMed ID: 21233180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo characterization of novel 18F-labeled bombesin analogues for targeting GRPR-positive tumors.
    Mu L; Honer M; Becaud J; Martic M; Schubiger PA; Ametamey SM; Stellfeld T; Graham K; Borkowski S; Lehmann L; Dinkelborg L; Srinivasan A
    Bioconjug Chem; 2010 Oct; 21(10):1864-71. PubMed ID: 20857927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies.
    Faintuch BL; Teodoro R; Duatti A; Muramoto E; Faintuch S; Smith CJ
    Nucl Med Biol; 2008 May; 35(4):401-11. PubMed ID: 18482677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization and evaluation of DOTA-conjugated Bombesin/RGD-antagonists for prostate cancer tumor imaging and therapy.
    Stott Reynolds TJ; Schehr R; Liu D; Xu J; Miao Y; Hoffman TJ; Rold TL; Lewis MR; Smith CJ
    Nucl Med Biol; 2015 Feb; 42(2):99-108. PubMed ID: 25459113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-terminal modifications improve the receptor affinity and pharmacokinetics of radiolabeled peptidic gastrin-releasing peptide receptor antagonists: examples of 68Ga- and 64Cu-labeled peptides for PET imaging.
    Gourni E; Mansi R; Jamous M; Waser B; Smerling C; Burian A; Buchegger F; Reubi JC; Maecke HR
    J Nucl Med; 2014 Oct; 55(10):1719-25. PubMed ID: 25146125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems.
    Garrison JC; Rold TL; Sieckman GL; Figueroa SD; Volkert WA; Jurisson SS; Hoffman TJ
    J Nucl Med; 2007 Aug; 48(8):1327-37. PubMed ID: 17631556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1,2,3-Triazoles as amide bond mimics: triazole scan yields protease-resistant peptidomimetics for tumor targeting.
    Valverde IE; Bauman A; Kluba CA; Vomstein S; Walter MA; Mindt TL
    Angew Chem Int Ed Engl; 2013 Aug; 52(34):8957-60. PubMed ID: 23832715
    [No Abstract]   [Full Text] [Related]  

  • 39. 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer.
    Zhang X; Cai W; Cao F; Schreibmann E; Wu Y; Wu JC; Xing L; Chen X
    J Nucl Med; 2006 Mar; 47(3):492-501. PubMed ID: 16513619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 99mTc radiotracers based on human GRP(18-27): synthesis and comparative evaluation.
    Marsouvanidis PJ; Maina T; Sallegger W; Krenning EP; de Jong M; Nock BA
    J Nucl Med; 2013 Oct; 54(10):1797-803. PubMed ID: 24009275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.